The Life Sciences sector continues to drive transformative healthcare solutions, creating substantial opportunities for companies in pharmaceutical, medical devices, nutraceutical, and biotechnology sectors. TLP provides comprehensive legal counsel to companies in the sector for U.S. market entry, regulatory compliance, and strategic business relationships. Our expertise includes:
- Pharmaceuticals and parapharmaceuticals
- Medical devices and diagnostic equipment
- Dietary supplements and nutraceuticals
- Biotechnology and research development
- Contract manufacturing and development
- Veterinary products and animal health
- Audiology and hearing solutions
- Clinical research and development
- Regulatory affairs and FDA compliance
REPRESENTATIVE TRANSACTIONS
Corporate restructuring and market entry
- Supported a leading Italian company in the production of probiotic microorganisms for the pharmaceutical and nutraceutical industry in the corporate restructuring of its U.S. subsidiary, followed by negotiation and drafting of multiple commercial agreements including research and development agreements, supply agreements, employment contracts, sales representative agreements, and confidentiality agreements
- Assisted an Italian company operating in the audiology sector specialized in the design and production of cutting-edge medical devices for prestigious brands including Amplifon, in structuring its U.S. subsidiary and establishing a strategic market positioning
- Guided an Italian artificial intelligence company focused on advancing life sciences and healthcare transformation through technology in U.S. legal matters related to its acquisition by U.S. healthcare company Alira Health LLC Strategic commercial agreements
- Represented an Italian contract development and manufacturing organization (CDMO) specialized in pharmaceutical products for veterinary use in negotiating and drafting a supply agreement with an important U.S. commercial partner
- Guided a premedical manufacturing company that produces medical components and devices for pharmaceutical and biomedical companies in negotiating and drafting a distribution agreement for U.S. market expansion
Attorney Advertising.
